Nature Communications, 2024 Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank Papier K., Atkins J., Tong T. et al. Olink Explore 3072/384OncologyPathophysiologyPatient StratificationPlasma | | | | |
Frontiers in Psychiatry, 2024 Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts Sokolov A., Lafta M., Nordberg D. et al. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
EMBO Molecular Medicine, 2024 Electron transport chain capacity expands yellow fever vaccine immunogenicity Mok D., Tng D., Yee J. et al. Olink Target 48Infectious DiseasesPathophysiologyPlasma | | | | |
Journal of the Neurological Sciences, 2024 Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation Jakimovski D., Qureshi F., Ramanathan M. et al. Olink FocusNeurologyPatient StratificationSerum | | | | |
JAMA Network Open, 2024 Cord Blood Proteomic Profiles, Birth Weight, and Early Life Growth Trajectories Van Pee T., Martens D., Alfano R. et al. Olink Explore 3072/384ObstetricsPathophysiologyPatient StratificationCord Blood | | | | |
Cell Genomics, 2024 Ribosomal DNA copy number variation associates with hematological profiles and renal function in the UK Biobank Rodriguez-Algarra F., Evans D., Rakyan V. Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma | | | | |
Alzheimer's Research & Therapy, 2024 Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy Vervuurt M., Kuiperij H., de Kort A. et al. Olink Explore 3072/384NeurologyPatient StratificationCSF | | | | |
Journal of Allergy and Clinical Immunology, 2024 Loss of the TRPM4 channel in humans causes immune dysregulation with defective monocyte migration Yu F., Hubrack S., Raynaud C. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |
Clinical and Translational Medicine, 2024 Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial Man X., Huang J., Sun S. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
JHLT Open, 2024 Proteomics early after heart transplantation and relation to coronary intimal changes and prognosis Dalsgaard R., Clemmensen T., Eiskjær H. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
BMC Medicine, 2024 Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank Wang X., Shi Z., Qiu Y. et al. Olink Explore 3072/384NeurologyPatient StratificationPlasma | | | | |
Clinical Immunology, 2024 Serum proteomics reveals hemophagocytic lymphohistiocytosis-like phenotype in a subset of patients with multisystem inflammatory syndrome in children Tulling A., Holierhoek M., Jansen-Hoogendijk A. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologyPatient StratificationSerum | | | | |
PROTEOMICS – Clinical Applications, 2024 Methods and clinical biomarker discovery for targeted proteomics using Olink technology Wang H., Zhao T., Zeng J. et al. Wider Proteomics StudiesReview/editorial | | | | |
Immunology & Cell Biology, 2024 Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation Alexandersson A., Venäläinen M., Heikkilä N. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma | | | | |
Frontiers in Immunology, 2024 Plasma proteomics analysis of Chinese HIV-1 infected individuals focusing on the immune and inflammatory factors afford insight into the viral control mechanism Ni W., Ren L., Liao L. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
BMJ Oncology, 2024 First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours Naing A., Papadopoulos K., Pishvaian M. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Ticks and Tick-borne Diseases, 2024 Diagnostic patterns of serum inflammatory protein markers in children with Lyme neuroborreliosis Fredriksson T., Brudin L., Henningsson A. et al. Olink Target 96Infectious DiseasesPatient StratificationSerum | | | | |
Biomolecules, 2024 GlycA and CRP Are Genetically Correlated: Insight into the Genetic Architecture of Inflammageing Kasher M., Freidin M., Williams F. et al. Olink Target 96Immunological & Inflammatory DiseasesAgingPathophysiologyBlood | | | | |
Journal of the European Academy of Dermatology and Venereology, 2024 Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis Soenen R., Schots L., Wang Z. et al. Olink Target 96Dermatological DiseasesPatient StratificationSerum | | | | |
Clinical Immunology, 2024 Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestation Reiter A., Verweyen E., Queste E. et al. Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologySerum | | | | |